Literature DB >> 21367732

Update on human immunodeficiency virus (HIV)-2 infection.

Omobolaji T Campbell-Yesufu1, Rajesh T Gandhi.   

Abstract

Infection with human immunodeficiency virus type 2 (HIV-2) occurs mainly in West Africa, but an increasing number of cases have been recognized in Europe, India, and the United States. In this era of global integration, clinicians must be aware of when to consider the diagnosis of HIV-2 infection and how to test for this virus. Although there is debate regarding when therapy should be initiated and which regimen should be chosen, recent trials have provided important information on treatment options for HIV-2 infection. In this review, we present information on recent clinical advances in our understanding of HIV-2 infection and highlight remaining diagnostic and therapeutic challenges.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21367732      PMCID: PMC3106263          DOI: 10.1093/cid/ciq248

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  60 in total

1.  Non-immune thrombocytopenia responsive to antiretroviral therapy and HIV-2 infection.

Authors:  Jaime R Torres; Maria A Torres-Viera; Jorg Schupbach; Hector R Rangel; Flor H Pujol
Journal:  J Infect       Date:  2006-05-26       Impact factor: 6.072

2.  CD4 cell recovery in treated HIV-2-infected adults is lower than expected: results from the French ANRS CO5 HIV-2 cohort.

Authors:  Sophie Matheron; Florence Damond; Antoine Benard; Audrey Taieb; Pauline Campa; Gilles Peytavin; Sophie Pueyo; Francoise Brun-Vezinet; Genevieve Chene
Journal:  AIDS       Date:  2006-02-14       Impact factor: 4.177

3.  Prevalence of HIV-associated nephropathy in autopsies of HIV-infected patients.

Authors:  V Shahinian; S Rajaraman; M Borucki; J Grady; W M Hollander; T S Ahuja
Journal:  Am J Kidney Dis       Date:  2000-05       Impact factor: 8.860

4.  Direct evidence of lower viral replication rates in vivo in human immunodeficiency virus type 2 (HIV-2) infection than in HIV-1 infection.

Authors:  Adam MacNeil; Abdoulaye Dieng Sarr; Jean-Louis Sankalé; Seema Thakore Meloni; Souleymane Mboup; Phyllis Kanki
Journal:  J Virol       Date:  2007-02-28       Impact factor: 5.103

5.  Detection of JC virus in two African cases of progressive multifocal leukoencephalopathy including identification of JCV type 3 in a Gambian AIDS patient.

Authors:  G L Stoner; H T Agostini; C F Ryschkewitsch; M Mazló; F Gullotta; W Wamukota; S Lucas
Journal:  J Med Microbiol       Date:  1998-08       Impact factor: 2.472

6.  Good response to lopinavir/ritonavir-containing antiretroviral regimens in antiretroviral-naive HIV-2-infected patients.

Authors:  Antoine Bénard; Florence Damond; Pauline Campa; Gilles Peytavin; Diane Descamps; Caroline Lascoux-Combes; Audrey Taieb; François Simon; Brigitte Autran; Françoise Brun-Vézinet; Geneviève Chêne; Sophie Matheron
Journal:  AIDS       Date:  2009-06-01       Impact factor: 4.177

7.  Inhibition of HIV-2 protease by HIV-1 protease inhibitors in clinical use.

Authors:  Evan T Brower; Usman M Bacha; Yuko Kawasaki; Ernesto Freire
Journal:  Chem Biol Drug Des       Date:  2008-02-28       Impact factor: 2.817

8.  Susceptibility of HIV-2, SIV and SHIV to various anti-HIV-1 compounds: implications for treatment and postexposure prophylaxis.

Authors:  Myriam Witvrouw; Christophe Pannecouque; William M Switzer; Thomas M Folks; Erik De Clercq; Walid Heneine
Journal:  Antivir Ther       Date:  2004-02

9.  Is HIV-2- induced AIDS different from HIV-1-associated AIDS? Data from a West African clinic.

Authors:  Euridice Martinez-Steele; Akum Aveika Awasana; Tumani Corrah; Saihou Sabally; Marianne van der Sande; Assan Jaye; Toyin Togun; Ramu Sarge-Njie; Samuel J McConkey; Hilton Whittle; Maarten F Schim van der Loeff
Journal:  AIDS       Date:  2007-01-30       Impact factor: 4.177

Review 10.  HIV-2: the forgotten AIDS virus.

Authors:  Thushan I de Silva; Matthew Cotten; Sarah L Rowland-Jones
Journal:  Trends Microbiol       Date:  2008-10-27       Impact factor: 17.079

View more
  63 in total

Review 1.  Combination nucleoside/nucleotide reverse transcriptase inhibitors for treatment of HIV infection.

Authors:  Maxwell O Akanbi; Kimberly K Scarsi; Kimberly Scarci; Babafemi Taiwo; Robert L Murphy
Journal:  Expert Opin Pharmacother       Date:  2012-01       Impact factor: 3.889

2.  Performance of an alternative HIV diagnostic algorithm using the ARCHITECT HIV Ag/Ab Combo assay and potential utility of sample-to-cutoff ratio to discriminate primary from established infection.

Authors:  Eric M Ramos; Socorro Harb; Joan Dragavon; Paul Swenson; Joanne D Stekler; Robert W Coombs
Journal:  J Clin Virol       Date:  2013-08-26       Impact factor: 3.168

3.  Emerging infections of the central nervous system.

Authors:  Jennifer Lyons; Justin McArthur
Journal:  Curr Infect Dis Rep       Date:  2013-12       Impact factor: 3.725

4.  The Potency of Nef-Mediated SERINC5 Antagonism Correlates with the Prevalence of Primate Lentiviruses in the Wild.

Authors:  Anke Heigele; Dorota Kmiec; Kerstin Regensburger; Simon Langer; Lukas Peiffer; Christina M Stürzel; Daniel Sauter; Martine Peeters; Massimo Pizzato; Gerald H Learn; Beatrice H Hahn; Frank Kirchhoff
Journal:  Cell Host Microbe       Date:  2016-09-14       Impact factor: 21.023

5.  Viral Vector Biosafety in Laboratory Animal Research.

Authors:  Dalis E Collins; Jon D Reuter; Howard G Rush; Jason S Villano
Journal:  Comp Med       Date:  2017-06-01       Impact factor: 0.982

6.  Phase 1 Safety, Pharmacokinetics, and Pharmacodynamics of Dapivirine and Maraviroc Vaginal Rings: A Double-Blind Randomized Trial.

Authors:  Beatrice A Chen; Lori Panther; Mark A Marzinke; Craig W Hendrix; Craig J Hoesley; Ariane van der Straten; Marla J Husnik; Lydia Soto-Torres; Annalene Nel; Sherri Johnson; Nicola Richardson-Harman; Lorna K Rabe; Charlene S Dezzutti
Journal:  J Acquir Immune Defic Syndr       Date:  2015-11-01       Impact factor: 3.731

7.  Immune Control of HIV.

Authors:  Muthukumar Balasubramaniam; Jui Pandhare; Chandravanu Dash
Journal:  J Life Sci (Westlake Village)       Date:  2019-06

8.  Blood-borne viral infections in pediatric hemodialysis.

Authors:  Shina Menon; Raj Munshi
Journal:  Pediatr Nephrol       Date:  2018-07-21       Impact factor: 3.714

9.  Assessment of the Cavidi ExaVir Load Assay for Monitoring Plasma Viral Load in HIV-2-Infected Patients.

Authors:  Pedro Borrego; Maria Fátima Gonçalves; Perpétua Gomes; Lavínia Araújo; Inês Moranguinho; Inês Brito Figueiredo; Isabel Barahona; José Rocha; Claudino Mendonça; Maria Cesarina Cruz; Jorge Barreto; Nuno Taveira
Journal:  J Clin Microbiol       Date:  2017-05-17       Impact factor: 5.948

10.  HIV 2: A Benign Onlooker or A Subtle Threat?

Authors:  Ekadashi Rajni Sabharwal; Shweta Gupta; Gaurav Dalela
Journal:  J Clin Diagn Res       Date:  2014-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.